The Pathogenesis of Nonalcoholic Steatohepatitis and Other Fatty Liver Diseases: A Four-Step Model including the Role of Lipid Release and Hepatic Venular Obstruction in the Progression to Cirrhosis

 

 Buy Article Permissions and Reprints

Fatty liver disease involves the accumulation of triglycerides in hepatocytes, necrosis of hepatocytes, inflammation, and often fibrosis with progression to cirrhosis. The two-hit model summarizes the important early metabolic events leading to hepatocellular necrosis in nonalcoholic steatohepatitis (NASH). In this article, we provide evidence of lipid release from hepatocytes in posttransplant fat necrosis and in NASH and quantify vascular obliteration in a series of biopsies with NASH. Obliteration of small hepatic veins (<30 μm) in small numbers is compensated by collateral flow. Obliteration of larger hepatic veins (>30 μm) is associated with fibrotic collapse lesions that are not easily resorbed. Based on these observations, we propose a new four-step model that includes the later events that lead to cirrhosis after necrosis has occurred. This model is applicable to nonalcoholic fatty liver disease (NAFLD), alcoholic disease, postjejunoileal bypass disease, and posttransplant fat necrosis. The first step is steatosis facilitated by insulin, and the second is necrosis induced by intracellular lipid toxicity or lipid peroxidation, or both, modified by alcohol, drugs, and ischemia. The third step is release of bulk lipid from hepatocytes into the interstitium leading to direct and inflammatory injury to hepatic veins. The fourth step is venous obstruction with secondary collapse and ultimately fibrous septation and cirrhosis.

REFERENCES

• 1 Wanless I R, Bargman J M, Oreopoulos D G, Vas S I. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity.  Mod Pathol. 1989;  2 69-74
  PubMedGoogle Scholar
• 2 Woodside W F, Heimberg M. The metabolism of oleic acid by the perfused rat liver in experimental diabetes induced by antiinsulin serum.  Metabolism. 1978;  27 1763-1777
  CrossrefPubMedGoogle Scholar
• 3 Sohn J, Siegelman E, Osiason A. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging.  AJR Am J Roentgenol. 2001;  176 471-474
  PubMedGoogle Scholar
• 4 Battaglia D M, Wanless I R, Brady A P, Mackenzie R L. Intrahepatic sequestered segment of liver presenting as focal fatty change.  Am J Gastroenterol. 1995;  90 2238-2239
  PubMedGoogle Scholar
• 5 Redston M, Wanless I R. The effect of insulin on development of fatty liver in choline deficient rats.  Mod Pathol. 1991;  4 95A
  PubMedGoogle Scholar
• 6 Wanless I R, Lentz J S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.  Hepatology. 1990;  12 1106-1110
  CrossrefPubMedGoogle Scholar
• 7 King E G, Nakane P K, Ashbaugh D G. The canine oleic acid model of fibrin localization in fat embolism.  Surgery. 1971;  69 782-787
  PubMedGoogle Scholar
• 8 Mavrelis P G, Ammon H V, Gleysteen J J, Komorowski R A, Charaf U K. Hepatic free fatty acids in alcoholic liver disease and morbid obesity.  Hepatology. 1983;  3 226-231
  PubMedGoogle Scholar
• 9 Day C P, James O F. Steatohepatitis: a tale of two “hits”?.  Gastroenterology. 1998;  114 842-845
  CrossrefPubMedGoogle Scholar
• 10 Caldwell S H, Swerdlow R H, Khan E M et al.. Mitochondrial abnormalities in non-alcoholic steatohepatitis.  J Hepatol. 1999;  31 430-434
  CrossrefPubMedGoogle Scholar
• 11 Sanyal A J, Campbell-Sargent C, Mirshahi F et al.. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.  Gastroenterology. 2001;  120 1183-1192
  CrossrefPubMedGoogle Scholar
• 12 Diehl A M. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines.  Am J Physiol Gastrointest Liver Physiol. 2002;  282 G1-G5
  CrossrefPubMedGoogle Scholar
• 13 Videla L A, Rodrigo R, Orellana M et al.. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.  Clin Sci (Lond). 2003;  103 261-268
  PubMedGoogle Scholar
• 14 Neuschwander-Tetri B A, Caldwell S H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.  Hepatology. 2003;  37 1202-1219
  CrossrefPubMedGoogle Scholar
• 15 Wanless I R, Sweeney G, Dhillon A P et al.. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia.  Blood. 2002;  100 1566-1569
  CrossrefPubMedGoogle Scholar
• 16 Cha I, Bass N, Ferrell L D. Lipopeliosis. An immunohistochemical and clinicopathologic study of five cases.  Am J Surg Pathol. 1994;  18 789-795
  PubMedGoogle Scholar
• 17 Edmondson H A, Peters R L, Reynolds T B, Kuzma O T. Sclerosing hyaline necrosis of the liver in the chronic alcoholic. a recognizable clinical syndrome.  Ann Intern Med. 1963;  59 646-673
  PubMedGoogle Scholar
• 18 Edmondson H A, Peters R L, Frankel H H, Borowsky S. The early stage of liver injury in the alcoholic.  Medicine (Baltimore). 1967;  46 119-129
  PubMedGoogle Scholar
• 19 Brunt E M, Tiniakos D G. Pathology of steatohepatitis.  Best Pract Res Clin Gastroenterol. 2002;  16 691-707
  CrossrefPubMedGoogle Scholar
• 20 Goodman Z D, Ishak K G. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases.  Gastroenterology. 1982;  83 786-796
  PubMedGoogle Scholar
• 21 Nakanuma Y, Ohta G, Doishita K. Quantitation and serial section observations of focal veno-occlusive lesions of hepatic veins in liver cirrhosis.  Virchows Arch A Pathol Anat Histopathol. 1985;  405 429-438
  CrossrefPubMedGoogle Scholar
• 22 Burt A D, MacSween R N. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study.  J Clin Pathol. 1986;  39 63-67
  PubMedGoogle Scholar
• 23 Wanless I R, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.  Arch Pathol Lab Med. 2000;  124 1599-1607
  PubMedGoogle Scholar
• 24 Rimarenko S, Jagirdar J. Veno-occlusive syndrome of the liver in an alcoholic man.  Mt Sinai J Med. 1984;  51 292-294
  PubMedGoogle Scholar
• 25 Wanless I R. Vascular disorders. In: Macsween RNM, Burt AD, Portmann BC Pathology of the Liver, 4th ed. Edinburgh; Churchill Livingstone 2002: 539-574
  Google Scholar
• 26 Tanaka M, Wanless I R. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules.  Hepatology. 1998;  27 488-496
  CrossrefPubMedGoogle Scholar
• 27 Wanless I R, Shiota K, Heathcote E J. Role of hepatic vein obliteration in the progression of non-alcoholic steatohepatitis (NASH) to cirrhosis.  Hepatology. 2002;  36 730A
  PubMedGoogle Scholar
• 28 Shimamatsu K, Wanless I R. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver.  Hepatology. 1997;  26 343-350
  CrossrefPubMedGoogle Scholar
• 29 Nanji A A, Jokelainen K, Tipoe G L, Rahemtulla A, Dannenberg A J. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration.  J Pharmacol Exp Ther. 2001;  299 638-644
  PubMedGoogle Scholar
• 30 Day C P. Pathogenesis of steatohepatitis.  Best Pract Res Clin Gastroenterol. 2002;  16 663-678
  CrossrefPubMedGoogle Scholar

Ian R WanlessM.D. 

Department of Pathology, University Health Network-Toronto General Hospital

200 Elizabeth Street, Room E4-305

Toronto, Ontario, Canada M5G 2C4

Email: ian.wanless@utoronto.ca